<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="nihpa" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC5568699/" /><meta name="ncbi_app" content="pmc" />
        <!-- Logger end -->
        
        <title>SREBP1 contributes to resolution of pro-inflammatory TLR4 signaling by reprogramming fatty acid metabolism</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568699/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Cell metabolism" /><meta name="citation_title" content="SREBP1 contributes to resolution of pro-inflammatory TLR4 signaling by reprogramming fatty acid metabolism" /><meta name="citation_authors" content="Yumiko Oishi, Nathanael J. Spann, Verena M. Link, Evan D. Muse, Tobias Strid, Chantle Edillor, Matthew J. Kolar, Takashi Matsuzaka, Sumio Hayakawa, Jenhan Tao, Minna U. Kaikkonen, Aaron F. Carlin, Michael T. Lam, Ichiro Manabe, Hitoshi Shimano, Alan Saghatelian, Christopher K. Glass" /><meta name="citation_date" content="7 February 2017" /><meta name="citation_issue" content="2" /><meta name="citation_volume" content="25" /><meta name="citation_firstpage" content="412" /><meta name="citation_doi" content="10.1016/j.cmet.2016.11.009" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC5568699/?report=abstract" /><meta name="citation_pmid" content="28041958" /><meta name="DC.Title" content="SREBP1 contributes to resolution of pro-inflammatory TLR4 signaling by reprogramming fatty acid metabolism" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="NIH Public Access" /><meta name="DC.Contributor" content="Yumiko Oishi" /><meta name="DC.Contributor" content="Nathanael J. Spann" /><meta name="DC.Contributor" content="Verena M. Link" /><meta name="DC.Contributor" content="Evan D. Muse" /><meta name="DC.Contributor" content="Tobias Strid" /><meta name="DC.Contributor" content="Chantle Edillor" /><meta name="DC.Contributor" content="Matthew J. Kolar" /><meta name="DC.Contributor" content="Takashi Matsuzaka" /><meta name="DC.Contributor" content="Sumio Hayakawa" /><meta name="DC.Contributor" content="Jenhan Tao" /><meta name="DC.Contributor" content="Minna U. Kaikkonen" /><meta name="DC.Contributor" content="Aaron F. Carlin" /><meta name="DC.Contributor" content="Michael T. Lam" /><meta name="DC.Contributor" content="Ichiro Manabe" /><meta name="DC.Contributor" content="Hitoshi Shimano" /><meta name="DC.Contributor" content="Alan Saghatelian" /><meta name="DC.Contributor" content="Christopher K. Glass" /><meta name="DC.Date" content="2017 Feb 7" /><meta name="DC.Identifier" content="10.1016/j.cmet.2016.11.009" /><meta name="DC.Language" content="en" /><meta property="og:title" content="SREBP1 contributes to resolution of pro-inflammatory TLR4 signaling by reprogramming fatty acid metabolism" /><meta property="og:type" content="article" /><meta property="og:description" content="Macrophages play pivotal roles in both the induction and resolution phases of inflammatory processes. Macrophages have been shown to synthesize anti-inflammatory fatty acids in an LXR-dependent manner, but whether the production of these species contributes ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568699/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.9.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.9.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'/pmc/utils/ctxp/'" /><script type="text/javascript" src="/corehtml/pmc/ctxp/jquery.citationexporter.js">//</script><link rel="stylesheet" href="/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-hhspa.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC5568699/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC5568699/pdf/nihms891846.pdf" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="F4FC2E4DB4D384510000000000CC00C9.m_8" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>
    <body class="article">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br />
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="clone">Clone</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="nucest">EST</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="nucgss">GSS</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="pubmedhealth">PubMed Health</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option><option value="unigene">UniGene</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=hhs%20author%20manuscript[filter]" class="navlink">HHS Author Manuscripts</a></li><li class="accid">PMC5568699</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-hhspa.png" alt="Logo of nihpa" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,57,255,75" alt="About Author manuscripts" title="About Author manuscripts" href="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" ref="https://www.ncbi.nlm.nih.gov/pmc/about/authorms.html" /><area shape="rect" coords="256,57,500,75" alt="Submit a manuscript" title="Submit a manuscript" href="https://www.nihms.nih.gov/" ref="reftype=publisher&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext" /><area shape="rect" coords="0,0,499,74" alt="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" title="HHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;" href="https://www.ncbi.nlm.nih.gov/pmc/about/public-access/" ref="reftype=publisher&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext" /></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="small"><div class="inline_block eight_col va_top"><div><span id="pmcmata">Cell Metab</span>. Author manuscript; available in PMC 2017 Aug 23.</div><div></div><div>Published in final edited form as:</div><div style="margin-left:1em"><div class="fm-vol-iss-date"><a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=28041958" target="pmc_ext" ref="reftype=publisher&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access&amp;rendering-type=normal"><span class="cit">Cell Metab. 2017 Feb 7; 25(2): 412–427. </span></a></div><span class="fm-vol-iss-date">Published online 2016 Dec 29. </span> <span class="doi">doi:  <a href="//dx.doi.org/10.1016%2Fj.cmet.2016.11.009" target="pmc_ext" ref="reftype=other&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">10.1016/j.cmet.2016.11.009</a></span></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC5568699</span></div><div class="fm-citation-manuscriptid"><span class="fm-citation-ids-label">NIHMSID: </span><span>NIHMS891846</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/28041958">28041958</a></div></div></div></div></div><h1 class="content-title">SREBP1 contributes to resolution of pro-inflammatory TLR4 signaling by reprogramming fatty acid metabolism</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Oishi%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958" class="affpopup" co-rid="_co_idm140071847046768" co-class="co-affbox">Yumiko Oishi</a>,<sup>1,</sup><sup>2,</sup><sup>9,</sup><sup>10</sup> <a href="/pubmed/?term=Spann%20NJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958" class="affpopup" co-rid="_co_idm140071851965984" co-class="co-affbox">Nathanael J. Spann</a>,<sup>1,</sup><sup>9</sup> <a href="/pubmed/?term=Link%20VM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958" class="affpopup" co-rid="_co_idm140071868740096" co-class="co-affbox">Verena M. Link</a>,<sup>1,</sup><sup>8</sup> <a href="/pubmed/?term=Muse%20ED%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958" class="affpopup" co-rid="_co_idm140071844897520" co-class="co-affbox">Evan D. Muse</a>,<sup>1,</sup><sup>3</sup> <a href="/pubmed/?term=Strid%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958" class="affpopup" co-rid="_co_idm140071839423776" co-class="co-affbox">Tobias Strid</a>,<sup>1</sup> <a href="/pubmed/?term=Edillor%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958" class="affpopup" co-rid="_co_idm140071848649968" co-class="co-affbox">Chantle Edillor</a>,<sup>1</sup> <a href="/pubmed/?term=Kolar%20MJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958" class="affpopup" co-rid="_co_idm140071850301136" co-class="co-affbox">Matthew J. Kolar</a>,<sup>4</sup> <a href="/pubmed/?term=Matsuzaka%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958" class="affpopup" co-rid="_co_idm140071849666432" co-class="co-affbox">Takashi Matsuzaka</a>,<sup>5</sup> <a href="/pubmed/?term=Hayakawa%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958" class="affpopup" co-rid="_co_idm140071987568816" co-class="co-affbox">Sumio Hayakawa</a>,<sup>2</sup> <a href="/pubmed/?term=Tao%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958" class="affpopup" co-rid="_co_idm140071847710448" co-class="co-affbox">Jenhan Tao</a>,<sup>1</sup> <a href="/pubmed/?term=Kaikkonen%20MU%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958" class="affpopup" co-rid="_co_idm140071839626592" co-class="co-affbox">Minna U. Kaikkonen</a>,<sup>1,</sup><sup>6</sup> <a href="/pubmed/?term=Carlin%20AF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958" class="affpopup" co-rid="_co_idm140071866412592" co-class="co-affbox">Aaron F. Carlin</a>,<sup>1</sup> <a href="/pubmed/?term=Lam%20MT%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958" class="affpopup" co-rid="_co_idm140071843555408" co-class="co-affbox">Michael T. Lam</a>,<sup>1</sup> <a href="/pubmed/?term=Manabe%20I%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958" class="affpopup" co-rid="_co_idm140071989941072" co-class="co-affbox">Ichiro Manabe</a>,<sup>7</sup> <a href="/pubmed/?term=Shimano%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958" class="affpopup" co-rid="_co_idm140071838785552" co-class="co-affbox">Hitoshi Shimano</a>,<sup>5</sup> <a href="/pubmed/?term=Saghatelian%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958" class="affpopup" co-rid="_co_idm140072030100528" co-class="co-affbox">Alan Saghatelian</a>,<sup>4</sup> and  <a href="/pubmed/?term=Glass%20CK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958" class="affpopup" co-rid="_co_idm140071856394512" co-class="co-affbox">Christopher K. Glass</a><sup>1,</sup><sup>10,</sup><sup>11</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140071847046768"><h3 class="no_margin">Yumiko Oishi</h3><p>  <sup>1</sup>Department of Cellular and Molecular Medicine, School of Medicine, University of California, San Diego</p><p>  <sup>2</sup>Department of Cellular and Molecular Medicine, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan</p><div>Find articles by <a href="/pubmed/?term=Oishi%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958">Yumiko Oishi</a></div></div><div id="_co_idm140071851965984"><h3 class="no_margin">Nathanael J. Spann</h3><p>  <sup>1</sup>Department of Cellular and Molecular Medicine, School of Medicine, University of California, San Diego</p><div>Find articles by <a href="/pubmed/?term=Spann%20NJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958">Nathanael J. Spann</a></div></div><div id="_co_idm140071868740096"><h3 class="no_margin">Verena M. Link</h3><p>  <sup>1</sup>Department of Cellular and Molecular Medicine, School of Medicine, University of California, San Diego</p><p>  <sup>8</sup>Faculty of Biology, Department II, Ludwig-Maximilians Universit&#x000e4;t M&#x000fc;nchen, Planegg-Martinsried 82152, Germany</p><div>Find articles by <a href="/pubmed/?term=Link%20VM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958">Verena M. Link</a></div></div><div id="_co_idm140071844897520"><h3 class="no_margin">Evan D. Muse</h3><p>  <sup>1</sup>Department of Cellular and Molecular Medicine, School of Medicine, University of California, San Diego</p><p>  <sup>3</sup>Scripps Translational Science Institute, La Jolla, CA</p><div>Find articles by <a href="/pubmed/?term=Muse%20ED%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958">Evan D. Muse</a></div></div><div id="_co_idm140071839423776"><h3 class="no_margin">Tobias Strid</h3><p>  <sup>1</sup>Department of Cellular and Molecular Medicine, School of Medicine, University of California, San Diego</p><div>Find articles by <a href="/pubmed/?term=Strid%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958">Tobias Strid</a></div></div><div id="_co_idm140071848649968"><h3 class="no_margin">Chantle Edillor</h3><p>  <sup>1</sup>Department of Cellular and Molecular Medicine, School of Medicine, University of California, San Diego</p><div>Find articles by <a href="/pubmed/?term=Edillor%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958">Chantle Edillor</a></div></div><div id="_co_idm140071850301136"><h3 class="no_margin">Matthew J. Kolar</h3><p>  <sup>4</sup>Salk Institute for Biological Studies, La Jolla, CA</p><div>Find articles by <a href="/pubmed/?term=Kolar%20MJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958">Matthew J. Kolar</a></div></div><div id="_co_idm140071849666432"><h3 class="no_margin">Takashi Matsuzaka</h3><p>  <sup>5</sup>Department of Internal Medicine (Endocrinology and Metabolism), Faculty of Medicine, Graduate School of Comprehensive Human Sciences, International Institute for Integrative Sleep Medicine (WPI-IIIS), and Center for Tsukuba Advanced Research Alliance, University of Tsukuba, Japan</p><div>Find articles by <a href="/pubmed/?term=Matsuzaka%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958">Takashi Matsuzaka</a></div></div><div id="_co_idm140071987568816"><h3 class="no_margin">Sumio Hayakawa</h3><p>  <sup>2</sup>Department of Cellular and Molecular Medicine, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan</p><div>Find articles by <a href="/pubmed/?term=Hayakawa%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958">Sumio Hayakawa</a></div></div><div id="_co_idm140071847710448"><h3 class="no_margin">Jenhan Tao</h3><p>  <sup>1</sup>Department of Cellular and Molecular Medicine, School of Medicine, University of California, San Diego</p><div>Find articles by <a href="/pubmed/?term=Tao%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958">Jenhan Tao</a></div></div><div id="_co_idm140071839626592"><h3 class="no_margin">Minna U. Kaikkonen</h3><p>  <sup>1</sup>Department of Cellular and Molecular Medicine, School of Medicine, University of California, San Diego</p><p>  <sup>6</sup>A.I. Virtanen Institute for Molecular Sciences, Department of Biotechnology and Molecular Medicine, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, Finland</p><div>Find articles by <a href="/pubmed/?term=Kaikkonen%20MU%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958">Minna U. Kaikkonen</a></div></div><div id="_co_idm140071866412592"><h3 class="no_margin">Aaron F. Carlin</h3><p>  <sup>1</sup>Department of Cellular and Molecular Medicine, School of Medicine, University of California, San Diego</p><div>Find articles by <a href="/pubmed/?term=Carlin%20AF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958">Aaron F. Carlin</a></div></div><div id="_co_idm140071843555408"><h3 class="no_margin">Michael T. Lam</h3><p>  <sup>1</sup>Department of Cellular and Molecular Medicine, School of Medicine, University of California, San Diego</p><div>Find articles by <a href="/pubmed/?term=Lam%20MT%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958">Michael T. Lam</a></div></div><div id="_co_idm140071989941072"><h3 class="no_margin">Ichiro Manabe</h3><p>  <sup>7</sup>Department of Aging Research, Graduate School of Medicine, Chiba University, Chiba, Japan</p><div>Find articles by <a href="/pubmed/?term=Manabe%20I%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958">Ichiro Manabe</a></div></div><div id="_co_idm140071838785552"><h3 class="no_margin">Hitoshi Shimano</h3><p>  <sup>5</sup>Department of Internal Medicine (Endocrinology and Metabolism), Faculty of Medicine, Graduate School of Comprehensive Human Sciences, International Institute for Integrative Sleep Medicine (WPI-IIIS), and Center for Tsukuba Advanced Research Alliance, University of Tsukuba, Japan</p><div>Find articles by <a href="/pubmed/?term=Shimano%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958">Hitoshi Shimano</a></div></div><div id="_co_idm140072030100528"><h3 class="no_margin">Alan Saghatelian</h3><p>  <sup>4</sup>Salk Institute for Biological Studies, La Jolla, CA</p><div>Find articles by <a href="/pubmed/?term=Saghatelian%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958">Alan Saghatelian</a></div></div><div id="_co_idm140071856394512"><h3 class="no_margin">Christopher K. Glass</h3><p>  <sup>1</sup>Department of Cellular and Molecular Medicine, School of Medicine, University of California, San Diego</p><div>Find articles by <a href="/pubmed/?term=Glass%20CK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=28041958">Christopher K. Glass</a></div></div></div></div><div class="fm-panel small half_rhythm"><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140071850236112_ai" style="display:none"><div class="fm-affl" lang="en" id="A1">  <sup>1</sup>Department of Cellular and Molecular Medicine, School of Medicine, University of California, San Diego</div><div class="fm-affl" lang="en" id="A2">  <sup>2</sup>Department of Cellular and Molecular Medicine, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan</div><div class="fm-affl" lang="en" id="A3">  <sup>3</sup>Scripps Translational Science Institute, La Jolla, CA</div><div class="fm-affl" lang="en" id="A4">  <sup>4</sup>Salk Institute for Biological Studies, La Jolla, CA</div><div class="fm-affl" lang="en" id="A5">  <sup>5</sup>Department of Internal Medicine (Endocrinology and Metabolism), Faculty of Medicine, Graduate School of Comprehensive Human Sciences, International Institute for Integrative Sleep Medicine (WPI-IIIS), and Center for Tsukuba Advanced Research Alliance, University of Tsukuba, Japan</div><div class="fm-affl" lang="en" id="A6">  <sup>6</sup>A.I. Virtanen Institute for Molecular Sciences, Department of Biotechnology and Molecular Medicine, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, Finland</div><div class="fm-affl" lang="en" id="A7">  <sup>7</sup>Department of Aging Research, Graduate School of Medicine, Chiba University, Chiba, Japan</div><div class="fm-affl" lang="en" id="A8">  <sup>8</sup>Faculty of Biology, Department II, Ludwig-Maximilians Universit&#x000e4;t M&#x000fc;nchen, Planegg-Martinsried 82152, Germany</div><div id="FN1"><sup>10</sup>Address correspondence to <a href="mailto:dev@null" data-email="pj.ca.nimu@cric-ihsioouy" class="oemail">pj.ca.nimu@cric-ihsioouy</a> and <a href="mailto:dev@null" data-email="ude.dscu@gkc" class="oemail">ude.dscu@gkc</a></div><div id="FN2"><sup>9</sup>Equivalent contributions</div><div id="FN3"><sup>11</sup>Lead contact</div></div><div class="togglers"><a href="#" class="pmctoggle" rid="idm140071850236112_ai">Author information <span>►</span></a> <a href="#" class="pmctoggle" rid="idm140071850236112_cpl">Copyright and License information <span>►</span></a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="fm-cpl-info fm-panel hide half_rhythm" id="idm140071850236112_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright notice</a> </div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="small"><div>The publisher's final edited version of this article is available  at <a href="/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;retmode=ref&amp;cmd=prlinks&amp;id=28041958" target="pmc_ext" ref="reftype=publisher&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CArticle%7CRestricted%20Access&amp;rendering-type=normal">Cell Metab</a></div><div>See other articles in PMC that <a href="/pmc/articles/PMC5568699/citedby/">cite</a> the published article.</div></div></div></div><div class="sec"></div><div id="idm140071867317824" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140071867317824title">Abstract</h2><!--article-meta--><div><p id="P3" class="p p-first-last">Macrophages play pivotal roles in both the induction and resolution phases of inflammatory processes. Macrophages have been shown to synthesize anti-inflammatory fatty acids in an LXR-dependent manner, but whether the production of these species contributes to the resolution phase of inflammatory responses has not been established. Here, we identify a biphasic program of gene expression that drives production of anti-inflammatory fatty acids 12&#x02013;24h following TLR4 activation and contributes to down-regulation of mRNAs encoding pro-inflammatory mediators. Unexpectedly, rather than requiring LXRs, this late program of anti-inflammatory fatty acid biosynthesis is dependent on SREBP1 and results in the uncoupling of NF&#x003ba;B binding from gene activation. In contrast to previously identified roles of SREBP1 in promoting production of IL1&#x003b2; during the induction phase of inflammation, these studies provide evidence that SREBP1 also contributes to the resolution phase of TLR4-induced gene activation by reprogramming macrophage lipid metabolism.</p></div></div><div id="S1" class="tsec sec"><h2 class="head no_bottom_margin" id="S1title">Introduction</h2><p id="P4" class="p p-first">Failure to resolve endogenous or extrinsic inflammatory stimuli can lead to a chronic state of low-grade inflammation that results in cellular dysfunction and tissue damage (<a href="#R39" rid="R39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088749">Tabas and Glass, 2013</a>). Recent studies have shown that the immune and metabolic systems are highly integrated with one another (<a href="#R4" rid="R4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088731">Cildir et al., 2013</a>). For instance, increased infiltration of pro-inflammatory macrophages in adipose tissue, liver and skeletal muscle and their release of cytokines that impair local insulin signaling contributes to insulin resistance (<a href="#R24" rid="R24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088754">Lumeng et al., 2008</a>; <a href="#R28" rid="R28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088803">Osborn and Olefsky, 2012</a>; <a href="#R41" rid="R41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088784">Tencerova et al., 2015</a>; <a href="#R42" rid="R42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088802">Varma et al., 2009</a>; <a href="#R43" rid="R43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088796">Wynn et al., 2013</a>; <a href="#R44" rid="R44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088750">Xu et al., 2003</a>). In addition, immune cell function itself is coordinately regulated with cellular metabolism (<a href="#R38" rid="R38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088755">Spann and Glass, 2013</a>). For example, upon inflammatory activation, macrophages rapidly induce glycolysis through HIF-1&#x003b1; and NF-&#x003ba;B, enabling them to trigger microbicidal activity even in a hypoxic inflammatory tissue environment (<a href="#R16" rid="R16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088779">Huang et al., 2014a</a>; <a href="#R34" rid="R34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088793">Rodriguez-Prados et al., 2010</a>; <a href="#R40" rid="R40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088745">Tannahill et al., 2013</a>). In contrast, macrophages display a shift to oxidative metabolism of glucose and fatty acids and acquire an anti-inflammatory phenotype in the context of tissue repair and remodeling (<a href="#R25" rid="R25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088771">Mantovani et al., 2013</a>; <a href="#R34" rid="R34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088762">Rodriguez-Prados et al., 2010</a>).</p><p id="P5">Macrophage activation in response to ligation of TLR4 provides a paradigm for investigation of molecular mechanisms that positively and negatively regulate inflammatory responses (<a href="#R20" rid="R20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088772">Iyer et al., 2010</a>; <a href="#R26" rid="R26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088780">Medzhitov and Horng, 2009</a>). TLR4 signaling induces immediate/early gene expression through activation of latent transcription factors that include members of the NF&#x003ba;B, IRF and AP-1 families (<a href="#R9" rid="R9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633271815">Glass and Natoli, 2015</a>; <a href="#R26" rid="R26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088751">Medzhitov and Horng, 2009</a>). These factors in turn induce secondary response genes via the production of type I interferons, TNF&#x003b1; and other signaling molecules. Collectively, the immediate/early and secondary responses drive expression of inflammatory response genes that support innate immunity and set the stage for adaptive immunity. TLR4 signaling also results in down-regulation of a broad program of gene expression, although molecular mechanisms are less well characterized.</p><p id="P6">Recent lipidomic analysis in macrophages revealed an immediate reduction of fatty acid synthesis in response to TLR4 activation, followed by an increase in eicosanoid synthesis that was linked to the arachidonic acid pathway and delayed responses characterized by sphingolipid and sterol biosynthesis (<a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088765">Dennis et al., 2010</a>). Lipid uptake is activated by chronic (~24 hours) LPS treatment, leading triglycerides to accumulate in lipid droplets within macrophages (<a href="#R7" rid="R7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088767">Feingold et al., 2012</a>; <a href="#R17" rid="R17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088758">Huang et al., 2014b</a>). These changes in lipid metabolism may be linked to changes in macrophage activity over the time-course of the response to LPS.</p><p id="P7">Macrophages can also synthesize anti-inflammatory fatty acids under the control of liver X receptors (LXRs) &#x003b1; and &#x003b2; (<a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088783">Li et al., 2013</a>; <a href="#R37" rid="R37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088756">Spann et al., 2012</a>). The LXR pathway is de-repressed following genetic deletion of the nuclear receptor co-repressor NCoR, leading to increased production of 9Z palmitoleic acid and polyunsaturated omega-3 and &#x02212;9 fatty acids (<a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088742">Li et al., 2013</a>). These fatty acids exert anti-inflammatory functions in macrophages in part by binding to G protein coupled receptors (<a href="#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088774">Oh da et al., 2010</a>). NCoR deletion in macrophages conferred protection of mice from high fat diet-induced inflammation and insulin resistance (<a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088768">Li et al., 2013</a>). Therefore, it is possible that anti-inflammatory fatty acids produced by the macrophage act in an autocrine/paracrine manner to regulate its function autonomously as well as the functions of surrounding parenchymal cells.</p><p id="P8">Cholesterol and fatty acid homeostasis are regulated at the level of transcription by LXRs and SREBPs 1 and 2 (<a href="#R10" rid="R10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088800">Goldstein et al., 2006</a>; <a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088785">Hong and Tontonoz, 2014</a>; <a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088732">Horton et al., 2002</a>). Their roles in cholesterol homeostasis are largely antagonistic. SREBPs (primarily SREBP2) drive transcriptional programs that increase cellular cholesterol synthesis and import (<a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088737">Horton et al., 2002</a>), while LXRs induce expression of genes that mediate cholesterol efflux and inhibit import (<a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088776">Hong and Tontonoz, 2014</a>). In contrast, LXRs and SREBPs (primarily SREBP1) function in a coordinate manner to positively regulate fatty acid biosynthesis. LXRs directly activate the expression of SREBP1c, and both LXRs and SREBP1 bind to and activate numerous genes involved in fatty acid biosynthesis (<a href="#R32" rid="R32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088736">Repa et al., 2000a</a>; <a href="#R35" rid="R35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088794">Schultz et al., 2000</a>). Further, at co-bound genomic loci, SREBP functions in a permissive manner, allowing signal-specific tailoring of LXR-mediated activation of lipid metabolic gene expression profiles (<a href="#R37" rid="R37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088764">Spann et al, Cell 2012</a>), resulting in context dependent synthesis and output of select lipid species.</p><p id="P9">LXRs and SREBPs also play important roles in regulating macrophage activation. LXRs primarily function to inhibit inflammatory responses by antagonizing pro-inflammatory transcription factors such as NF&#x003ba;B (<a href="#R8" rid="R8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088733">Ghisletti et al., 2009</a>; <a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088753">Hong and Tontonoz, 2014</a>) and by activating genes with anti-inflammatory activities, such as <em>Mer</em> and <em>Abca1</em> (<a href="#R11" rid="R11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088801">Gonzalez et al., 2009</a>; <a href="#R19" rid="R19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088792">Ito et al., 2015</a>). In contrast, SREBP1 has been found to promote the acute inflammatory response by regulating genes involve in the production of active Il1&#x003b2; (<a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088748">Im et al., 2011</a>; <a href="#R31" rid="R31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088757">Reboldi et al., 2014</a>). Further, the LXR pathway is subject to negative regulation by TLR4 (<a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088777">Castrillo et al., 2003</a>). This suggests that macrophage fatty acid synthesis is influenced by TLR signaling via temporal modulation of LXR activities.</p><p id="P10" class="p p-last">To address the question of whether TLR4 signaling regulates the production of anti-inflammatory fatty acids, we analyzed lipidomic data generated by the LIPD MAPs consortium evaluating the temporal response of primary mouse macrophages to the specific TLR4 agonist Kdo2 LIPID A (KLA) (<a href="http://www.lipidmaps.org/" ref="reftype=extlink&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">http://www.lipidmaps.org/</a>)(<a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088775">Dennis et al., 2010</a>). This analyses revealed that the intracellular content of anti-inflammatory mono- and poly- (&#x003c9;&#x02212;3,&#x02212;9) unsaturated fatty acids was rapidly decreased at early time points of TLR4-mediated inflammation; while the resolution phase was characterized by increased intracellular unsaturated fatty acid levels. This temporal pattern of changes in specific lipid species was correlated with changes in mRNAs encoding corresponding biosynthetic enzymes. Unexpectedly, we found that the late up-regulation of unsaturated fatty acid synthesis was independent of LXR, but was instead driven by SREBP1. Anti-inflammatory fatty acid synthesis was compromised in <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> macrophages at late time points compared to wild-type macrophages, concomitant with a hyper-inflammatory state due to impaired resolution of NF-&#x003ba;B associated activity and gene expression. Supplementation with exogenous mono- and polyunsaturated fatty acids rescues the late hyper-inflammatory response in both <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> macrophages and <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> mice. Collectively, these findings provide evidence that SREBP1 contributes to resolution of pro-inflammatory TLR4 signaling by reprogramming fatty acid metabolism.</p></div><div id="S2" class="tsec sec"><h2 class="head no_bottom_margin" id="S2title">Results</h2><div id="S3" class="sec sec-first"><h3>TLR4 signaling reprograms macrophage fatty acid metabolism</h3><p id="P11" class="p p-first">To investigate changes in macrophage fatty acid levels throughout the course of an inflammatory response, we utilized lipidomic data generated by the LIPID MAPS Consortium (<a href="http://www.lipidmaps.org/" ref="reftype=extlink&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">http://www.lipidmaps.org/</a>)(<a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088763">Dennis et al., 2010</a>). Metabolic pathways responsible for generation of long chain omega-3 fatty acids and 9Z palmitoleic acid (9Z&#x02013;POA) are shown in <a href="/pmc/articles/PMC5568699/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1A</span></a>. Activation of TLR4 by KLA, a chemically defined substructure of bacterial lipopolysaccharide (LPS) that is specifically recognized by Toll-like receptor 4 (<a href="#R30" rid="R30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088735">Raetz et al., 2006</a>), rapidly and transiently decreased the cellular content of most fatty acids analyzed (<a href="/pmc/articles/PMC5568699/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig.1B</span></a>). Unexpectedly, in addition to the known up-regulation of omega-6 fatty acids, such as arachidonic acid, the cellular content of anti-inflammatory omega-3 and omega-9 fatty acids was also significantly increased during the late inflammatory response (12&#x02013;24 hours after KLA treatment) (<a href="/pmc/articles/PMC5568699/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1B and 1C</span></a>). Based on estimates of cell volume, maximum intracellular concentrations of DHA are on the order of 10 &#x000b5;M and EPA and 9Z-POA are on the order of 2 &#x000b5;M.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC5568699/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140071856525664" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5568699_nihms891846f1.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms891846f1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC5568699/bin/nihms891846f1.jpg" /></a></div><div id="largeobj_idm140071856525664" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC5568699/figure/F1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC5568699/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Activation of TLR4 reprograms macrophage fatty acid metabolism</strong><p id="P48">A. Pathway maps illustrating omega-3 and &#x02212;9 pathways. Enzymes catalyzing each step are highlighted in blue.</p><p id="P49">B. Lipidomic analysis of saturated and unsaturated fatty acids (omega-3, &#x02212;6, &#x02212;7 and &#x02212;9) in thioglycollate-elicited macrophages treated with KLA for 0, 1, 6, 12, 24 hours.</p><p id="P50">C. Cellular content of omega-3 (DHA and EPA) and omega-7 (9Z-POA) fatty acids in thioglycollate-elicited macrophages treated with KLA for 0, 1, 6, 12, 24 hours.</p><p id="P51">D. Relative mRNA expression levels for <em>Scd2</em> and <em>Fads1</em> determined by microarray analysis of RNA from thioglycollate-elicited macrophages treated with KLA for 0, 1, 6, 24 hours.</p><p id="P52">E. Heat map of mRNA expression levels determined by RNA-Seq analysis of bone marrow-derived macrophages with KLA for 0, 1, 6, 24 hours (FDR &#x0003c; 0.01, RPKM &#x0003e; 0.5).</p><p id="P53">F. Functional annotations associated with genes exhibiting KLA repressed-induced temporal expression patterns.</p><p id="P54">G. Relative mRNA expression of <em>Scd2</em> and <em>Fads2</em> in human monocyte-derived macrophages treated with KLA for 0, 1, 6, and 24 hours.</p><p id="P55">Values are expressed as mean &#x000b1; SEM. *p&#x0003c;0.05, **p&#x0003c;0.01.</p><p id="P56">See also Figure S1.</p></div></div></div><p id="P12" class="p p-last">Analysis of microarray data from the same KLA-treated macrophages, generated by the LIPID MAPS Consortium (<a href="http://www.lipidmaps.org/" ref="reftype=extlink&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">http://www.lipidmaps.org/</a>)(<a href="#R6" rid="R6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088790">Dennis et al., 2010</a>), demonstrated biphasic expression of genes encoding enzymes involved in mono-unsaturated and omega-3 polyunsaturated fatty acid biosynthesis, exemplified by <em>Scd2</em>, <em>Fads1</em>, <em>Acox3</em>, and <em>Elovl5</em> (<a href="/pmc/articles/PMC5568699/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1D</span></a>, <a href="#SD1" rid="SD1" class=" supplementary-material">Suppl. Fig. 1</a>). To independently confirm these findings, we performed RNA-sequencing (RNA-seq), throughout a time course of KLA treatment. These experiments also revealed a common biphasic expression pattern for many of the genes involved in synthesis of unsaturated fatty acids, exemplified by <em>Scd1/2, Elovl5, Fads1, Acsl3</em>, and <em>Acox3</em> (<a href="/pmc/articles/PMC5568699/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1E</span></a>). This temporal pattern is characterized by an initial transient reduction within 1&#x02013;6 hours of TLR4 activation, and subsequent activation in the late phase of the TLR4 response (<a href="/pmc/articles/PMC5568699/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1D, E</span></a>). The rapid decrease in lipid species observed at 30 minutes (<a href="/pmc/articles/PMC5568699/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1B</span></a>) precedes the decrease in mRNA levels of biosynthetic genes (<a href="/pmc/articles/PMC5568699/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1D, E</span></a>), indicating that initial phase of reduced fatty acid levels is determined by post-transcriptional mechanisms. However, the increase in levels of mono and polyunsaturated fatty acids between 12 and 24 hours is correlated with increases in mRNA levels of corresponding biosynthetic genes. Whole transcriptome analysis revealed that among the 22,455 measurable transcripts, 2993 genes with RefSeq annotations were reduced &#x0003e;2.0-fold at 6 hours, and subsequently increased 2.0-fold at 24 hours after KLA treatment. We define this subset of KLA-regulated genes as KLA repressed-induced genes. Consistent with temporal changes in macrophage fatty acid content, the entire set of KLA repressed-induced genes was significantly enriched for functional annotations linked to lipid metabolism (<a href="/pmc/articles/PMC5568699/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1F</span></a>). Experiments in KLA-treated human monocyte-derived macrophages revealed a similar biphasic expression pattern for genes involved in synthesis of unsaturated fatty acids, exemplified by <em>Scd1</em> and <em>Fads2</em> (<a href="/pmc/articles/PMC5568699/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1G</span></a>). The temporal pattern characterized by induction in the late phase of the TLR4 response, suggests that the observed temporal dynamics of specific fatty acid metabolic reprogramming is conserved in humans. Collectively, these findings indicate that TLR4 signaling induces a biphasic reprogramming of fatty acid metabolism in macrophages through transcriptional and post-transcriptional mechanisms.</p></div><div id="S4" class="sec"><h3>Biphasic expression of fatty acid biosynthetic genes is independent of LXRs</h3><p id="P13" class="p p-first">Many enzymes involved in unsaturated fatty acid synthesis are products of LXR-regulated target genes (<a href="#R1" rid="R1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088791">Calkin and Tontonoz, 2012</a>; <a href="#R14" rid="R14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088752">Hong and Tontonoz, 2014</a>). Because TLR4 activation can repress LXR induction of gene expression (<a href="#R3" rid="R3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088797">Castrillo et al., 2003</a>), it is possible that altered LXR activity could account for the biphasic pattern of expression observed for genes involved in mono and polyunsaturated fatty acid biosynthesis. To address this possibility, we performed RNA-seq analysis of RNA recovered from macrophages treated with either vehicle or the synthetic LXR agonist GW3965. Approximately one fifth (19.3%) of LXR target genes (GW3965&#x0003e;vehicle 2-fold), are represented as KLA repressed-induced genes (<a href="/pmc/articles/PMC5568699/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2A</span></a>). In addition, gene ontology analysis revealed that both LXR-induced and KLA repressed-induced genes are enriched for similar functional annotations, including lipid metabolism and fatty acid metabolic process (<a href="/pmc/articles/PMC5568699/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2B</span></a>). To further examine the extent to which TLR4-mediated inflammation repressed LXR-dependent gene expression, macrophages were pretreated with vehicle or KLA, followed by treatment with either vehicle or the LXR agonist GW3965. RNA-seq revealed that LXR target gene activation was markedly attenuated by KLA pretreatment (~42% GW3965-induced genes, <a href="/pmc/articles/PMC5568699/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2C</span></a>), consistent with previous findings (<a href="#R21" rid="R21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088744">Joseph et al., 2003</a>). These TLR4-compromised, LXR target genes were significantly enriched for functional annotations linked to lipid transport, lipid localization, and fatty acid biosynthetic process (<a href="/pmc/articles/PMC5568699/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2D</span></a>). These data suggest that the macrophage LXR-regulatory program involved in synthesis of unsaturated fatty acid is repressed in the early phase of TLR4 activation, which could be important for allowing appropriate induction of the inflammatory response.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC5568699/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140071987521264" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5568699_nihms891846f2.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms891846f2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC5568699/bin/nihms891846f2.jpg" /></a></div><div id="largeobj_idm140071987521264" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC5568699/figure/F2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC5568699/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Genes required for anti-inflammatory fatty acid synthesis demonstrate biphasic temporal expression patterns following TLR4 ligation</strong><p id="P57">A. Venn diagram of overlap between LXR target genes (GW3965 induced genes &#x0003e;2-fold vs untreated) and KLA repressed-induced genes.</p><p id="P58">B. Functional annotations associated with LXR target genes induced by GW3965 treatment.</p><p id="P59">C. Scatter plot depicting the relationship between fold change of LXR target genes (GW3965 &#x0003e; 1.5-fold vs. untreated) comparing RNA-Seq data from thioglycollate-elicited macrophages treated with GW3965 (18 hours), with or without KLA pretreatment (100ng/ml for 2 hours).</p><p id="P60">D. Functional annotations associated with LXR target genes repressed by KLA treatment.</p><p id="P61">E. <em>Scd2, Elovl5</em> and <em>Fads1</em> mRNA expression in <em>LXR&#x003b1;/&#x003b2;</em><sup>&#x02212;/&#x02212;</sup> and WT thioglycollate-elicited macrophages treated with KLA for 0, 1, 6, 12, and 24 hours.</p><p id="P62">F. <em>De novo</em> motif analysis of LXR peaks in WT thioglycollate-elicited macrophages.</p><p id="P63">G. Normalized distribution LXR ChIP-Seq tag density, at enhancers vicinal to KLA repressed-induced genes, in thioglycollate-elicited macrophages treated with KLA for 0, 1, 6, 24 hours.</p><p id="P64">See also Figure S2.</p></div></div></div><p id="P14" class="p p-last">To assess whether the repression of LXR activity is required for the early reduction of unsaturated fatty acid related gene expression and production following KLA treatment, we took advantage of LXR-deficient macrophages. The temporal dynamics of TLR4 activation was assessed by expression profiling of KLA treated macrophages prepared from wild type and <em>LXR&#x003b1;/&#x003b2;</em><sup>&#x02212;/&#x02212;</sup> mice (<a href="#R33" rid="R33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088799">Repa et al., 2000b</a>). Unexpectedly, quantitative PCR analysis of the temporal mRNA expression patterns of genes involved in unsaturated fatty acid synthesis, exemplified by <em>Scd2</em>, <em>Elovl5</em> and <em>Fads1</em>, revealed similar patterns in <em>LXR&#x003b1;/&#x003b2;</em><sup>&#x02212;/&#x02212;</sup> and wild type macrophages (<a href="/pmc/articles/PMC5568699/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2E</span></a>). We further evaluated effects of TLR4 activation on the genome-wide location of endogenous LXRs by chromatin immunoprecipitation sequencing (ChIP-Seq). These studies revealed co-localization of LXRs with macrophage lineage-determining factors PU.1 and AP-1 based on motif co-enrichment (<a href="/pmc/articles/PMC5568699/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2F</span></a>), consistent with previous studies using tagged LXRs in RAW264.7 macrophages (<a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088788">Heinz et al., 2010</a>). Further, these studies revealed an unexpected finding that LXR binding at KLA repressed-induced loci significantly decreases in the late phase of inflammation (<a href="/pmc/articles/PMC5568699/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Fig. 2G</span></a>, <a href="#SD1" rid="SD1" class=" supplementary-material">Suppl. Fig. 2</a>). Thus temporal changes in LXR binding are disassociated from late phase induction of KLA repressed-induced genes.</p></div><div id="S5" class="sec"><h3>TLR4 signaling reprograms enhancer activities near repressed-induced genes</h3><p id="P15" class="p p-first">The unexpected finding that LXR is dispensable for late activation of genes directing fatty acid metabolism prompted us to analyze the local enhancer landscapes of these genes for candidate regulators associated with the temporal profile of repressed-induced genes. To identify enhancers exhibiting temporal activities associated with KLA repressed-induced genes, we performed ChIP-seq to analyze the dimethylation status of lysine 4 of histone H3 (H3K4me2), acetylation status of lysine 27 of histone H3 (H3K27ac), and RNA polymerase II (RNA polII) in naive and KLA-stimulated macrophages. Whereas H3K27ac and RNA polII correlate positively with active transcriptional activity (<a href="#R5" rid="R5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088761">Creyghton et al., 2010</a>; <a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088734">Kaikkonen et al., 2013</a>), deposition of H3K4me2 has been demonstrated as an indicator of both previous and current local transcription (<a href="#R12" rid="R12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088795">He et al., 2010</a>; <a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088747">Kaikkonen et al., 2013</a>; <a href="#R29" rid="R29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088773">Ostuni et al., 2013</a>).</p><p id="P16">Consistent with their reduced mRNA levels (<a href="/pmc/articles/PMC5568699/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1D</span></a>), genomic loci of representative KLA repressed-induced genes, exemplified by <em>Scd2/3</em>, <em>Acsl3</em>, and <em>Fads1</em>, are associated with decreased H3K27ac and H3K4me2 during the early phase inflammatory response at KLA 1 and 6 hours respectively (asterisks, <a href="/pmc/articles/PMC5568699/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3A</span></a>). Prior studies revealed that the lineage determining transcription factor (LDTF) PU.1 is necessary for establishing macrophage-specific cistromes for signal responsive transcription factors (<a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088741">Heinz et al., 2010</a>). Centering our analysis on PU.1-bound regions, we analyzed the temporal pattern of relevant features at enhancers associated with repressed-induced genes. Chromatin features of active transcription, defined by RNA polII and H3K27ac, were decreased during the early inflammation phase (at 1 h post KLA), then subsequently increased at 6 and 24 hours post KLA stimulation (<a href="/pmc/articles/PMC5568699/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3B</span></a>), preceding increased levels of nearby mRNA.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F3" co-legend-rid="lgnd_F3"><a href="/pmc/articles/PMC5568699/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140072029905760" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5568699_nihms891846f3.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms891846f3.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC5568699/bin/nihms891846f3.jpg" /></a></div><div id="largeobj_idm140072029905760" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC5568699/figure/F3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F3"><div><a class="figpopup" href="/pmc/articles/PMC5568699/figure/F3/" target="figure" rid-figpopup="F3" rid-ob="ob-F3">Figure 3</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Temporal dynamics of cis-reglatory elements associated with KLA repressed-induced genes</strong><p id="P65">A. UCSC genome browser images illustrating normalized tag counts for H3K4Me2 and H3K27Ac, at the LXR target genes in bone marrow-derived macrophages treated with KLA for 0, 1, 6 and 24 hours.</p><p id="P66">B. Distribution of RNA Pol II and H3K27Ac tag densities in vicinity of KLA repressed-induced enhancers in bone marrow-derived macrophages treated with KLA for 0, 1, 6, 24 hours.</p><p id="P67">C. Distribution of GRO-Seq tags at KLA repressed-induced enhancers in thioglycollate-elicited macrophages treated with KLA for 0, 1, 6, 24 hours.</p><p id="P68">D. Relative distribution of GRO-Seq tags at gene bodies of KLA repressed-induced genes in thioglycollate-elicited macrophages treated with KLA for 0, 1, 6, 24 hours.</p><p id="P69">E. Sequence motifs enriched at enhancers associated with KLA repressed-induced genes.</p></div></div></div><p id="P17">As a more direct analysis of active transcription, we analyzed global run-on sequencing (GRO-seq) data (<a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088766">Kaikkonen et al., 2013</a>), to measure nascent transcript levels at KLA repressed-induced loci. Consistent with enhancer ChIP-seq data, GRO-seq revealed that nascent RNA transcription at KLA repressed-induced enhancers follows a similar temporal profile, exhibited by early transcriptional repression and late response induction (<a href="/pmc/articles/PMC5568699/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3C</span></a>). Further, GRO-seq analysis revealed a conserved temporal pattern of transcription at associated KLA repressed-induced gene bodies (<a href="/pmc/articles/PMC5568699/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3D</span></a>). Collectively, these results suggest that KLA repressed-induced enhancer activity and gene transcription is transiently inhibited following inflammatory activation, ensuring decreased unsaturated fatty acid synthesis in macrophages. This is followed by subsequent late phase induction of relevant macrophage transcription and gene expression, culminating in increased unsaturated fatty acid synthesis and output by macrophages.</p><p id="P18" class="p p-last">To define transcription factors potentially determining this temporal regulation of KLA repressed-induced genes, we performed motif analysis on enhancers exhibiting the repressed/induced pattern of chromatin features. As expected, <em>de novo</em> motif analysis identified motifs for the macrophage LDTFs, PU.1, C/EBP and AP-1, as the most highly enriched sequences. Unexpectedly, an SREBP response element (SRE) was also highly enriched in repressed-induced associated enhancers (<a href="/pmc/articles/PMC5568699/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3E</span></a>). Given its role in regulation of fatty acid metabolism in various cell types, these findings suggested that SREBP1 might be a determinant of late inflammatory phase regulatory dynamics leading to induction of genes necessary for unsaturated fatty acid biosynthesis.</p></div><div id="S6" class="sec"><h3>SREBP1 activity is induced during the resolution phase of the inflammatory response</h3><p id="P19" class="p p-first">We previously demonstrated that LXR and SREBP1 not only co-localize to representative genes involved in maintaining cholesterol and fatty acid homeostasis, but their coordinate regulatory actions can control context-specific expression profiles (<a href="#R37" rid="R37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088770">Spann et al., 2012</a>). To investigate the potential relationships of LXR and SREBP1 in controlling macrophage lipid metabolism following TLR4 activation, we performed ChIP-seq of SREBP1 and LXR in mouse primary macrophages stimulated with ligands for LXR and TLR4 for 24hours. As expected, SREBP1 recruitment was observed in the enhancers of lipid synthesis-related genes, as exemplified by <em>Scd2</em>, <em>Acsl3</em> and <em>Srebf1</em> following GW3965, but not desmosterol treatment, which is a potent suppressor of SREBP processing (<a href="/pmc/articles/PMC5568699/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4A</span></a>). Further, LXR and SREBP1 cistromes exhibited significant overlap when comparing genome wide binding profiles (<a href="/pmc/articles/PMC5568699/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4A</span></a>, <a href="#SD1" rid="SD1" class=" supplementary-material">Suppl. Fig. 3A</a>). The genes associated with LXR-SREBP1 co-bound sites were enriched for functional annotations for fatty acid metabolism, and fatty acid biosynthesis and elongation (<a href="#SD1" rid="SD1" class=" supplementary-material">Suppl. Fig. 3B</a>). Further, temporal patterns for direct measurement of enhancer activity levels, demonstrated by H4K5ac and GRO-seq, revealed these LXR-SREBP1 co-bound regions exhibited a coordinate KLA repressed-induced profile (<a href="#SD1" rid="SD1" class=" supplementary-material">Suppl. Fig. 3C</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F4" co-legend-rid="lgnd_F4"><a href="/pmc/articles/PMC5568699/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140072063677520" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5568699_nihms891846f4.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms891846f4.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC5568699/bin/nihms891846f4.jpg" /></a></div><div id="largeobj_idm140072063677520" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC5568699/figure/F4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F4"><div><a class="figpopup" href="/pmc/articles/PMC5568699/figure/F4/" target="figure" rid-figpopup="F4" rid-ob="ob-F4">Figure 4</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>SREBP1 is recruited to repressed-induced enhancers during the resolution phase of the inflammatory response</strong><p id="P70">A. UCSC genome browser images illustrating normalized tag counts for SREBP1, LXR and H3K4Me2, at indicated loci, in thioglycollate-elicited macrophages treated with vehicle, KLA, GW3965, or desmosterol for 24 hours.</p><p id="P71">B. Known and <em>de novo</em> motifs identified in regions bound by SREBP1 in the late inflammatory response. For ChIP-seq peaks used in motif analysis, peaks for each SREBP ChIP were identified using Homer and calculated the Irreproducible Discovery Rate (IDR) to measure the consistency between replicate experiments for the strength of binding at each loci and retained SREBP1 peaks with IDR &#x0003c; 0.05.</p><p id="P72">C. Distribution of SREBP1 tag densities, at enhancers associated with genes exhibiting either repressed-repressed or repressed-induced temporal expression patterns, in thioglycollate-elicited macrophages treated with KLA for 24 hours.</p><p id="P73">See also Figure S3.</p></div></div></div><p id="P20" class="p p-last">Remarkably, KLA treatment also dramatically increased the binding of SREBP1 at enhancer-like regions associated with genes required for mono- and polyunsaturated fatty acid biosynthesis (<a href="/pmc/articles/PMC5568699/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4A</span></a>), consistent with the enrichment of the SREBP recognition element in repressed-induced enhancers (<a href="/pmc/articles/PMC5568699/figure/F3/" target="figure" class="fig-table-link figpopup" rid-figpopup="F3" rid-ob="ob-F3" co-legend-rid="lgnd_F3"><span>Fig. 3E</span></a>). Furthermore, rigorous peak analysis using HOMER defined peaks along with irreproducible discovery rate (IDR) analysis, identified the top known motif in the KLA-induced SREBP1 cistrome as matching the consensus sterol response element (<a href="/pmc/articles/PMC5568699/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4B</span></a>, top). The sterol response element was independently identified by <em>de novo</em> motif analysis of IDR-defined SREBP1 binding sites (<a href="/pmc/articles/PMC5568699/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4B</span></a> bottom). Multiple independent experiments indicated that the late phase KLA induction of SREBP1 binding activity was associated with parallel increased nuclear levels of mature SREBP1 protein, as determined by western blotting (<a href="#SD1" rid="SD1" class=" supplementary-material">Suppl. Fig. 3D</a>). Intriguingly, the late phase increase in SREBP1 recruitment is specific to KLA repressed-induced associated promoters and enhancers, as binding is not changed at regions of solely KLA-repressed genes (<a href="/pmc/articles/PMC5568699/figure/F4/" target="figure" class="fig-table-link figpopup" rid-figpopup="F4" rid-ob="ob-F4" co-legend-rid="lgnd_F4"><span>Fig. 4C</span></a>).</p></div><div id="S7" class="sec"><h3>SREBP1 drives TLR-responsive late activation of repressed-induced genes</h3><p id="P21" class="p p-first">The observation that SREBP1 was recruited to the genes involved in unsaturated fatty acid synthesis in the late inflammatory response led us to examine the consequences of <em>Srebf1</em> deletion in the inflammatory response of macrophages on a genome-wide scale. We performed RNA-Seq analysis of KLA treated bone marrow-derived macrophages (BMDM) prepared from wild type (WT) and <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> mice (<a href="#R36" rid="R36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088739">Shimano et al., 1997</a>) (<a href="/pmc/articles/PMC5568699/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5A and B</span></a>). We identified 2995 significantly expressed transcripts with RefSeq annotations exhibiting the KLA repressed-induced phenotype; characterized by reduced levels of &#x0003e;2-fold at 6 hours, and subsequently increased &#x0003e;2-fold at 24 hours after KLA treatment. The expression of 1047 these genes (~35%), in the KLA repressed-induced group, were significantly reduced at 24 hours post KLA treatment in <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> macrophages compared to levels in WT cells (<a href="/pmc/articles/PMC5568699/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5A and B</span></a>). Both RNA-seq and quantitative PCR analysis confirmed that <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> macrophages demonstrated significant reduction in the expression of genes mediating mono- and polyunsaturated fatty acid biosynthesis, exemplified by <em>Scd1/2</em>, <em>Acsl3</em>, <em>Fads1/2</em>, and <em>Acot2</em>, during the resolution phase of inflammation at 24 hours post KLA treatment (<a href="/pmc/articles/PMC5568699/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5C</span></a> and <a href="#SD1" rid="SD1" class=" supplementary-material">Suppl. Fig. 4A</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F5" co-legend-rid="lgnd_F5"><a href="/pmc/articles/PMC5568699/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140071860075120" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5568699_nihms891846f5.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms891846f5.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC5568699/bin/nihms891846f5.jpg" /></a></div><div id="largeobj_idm140071860075120" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC5568699/figure/F5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F5"><div><a class="figpopup" href="/pmc/articles/PMC5568699/figure/F5/" target="figure" rid-figpopup="F5" rid-ob="ob-F5">Figure 5</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong><em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> macrophages exhibit reduced fatty acid biosynthetic gene expression during the resolution phase of the TLR4 response</strong><p id="P74">A. Scatter plot depicting the relationship between fold change of KLA repressed-induced genes, comparing RNA-seq from wild-type (WT) versus <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> bone marrow-derived macrophages treated with KLA for 24 hours. Gray dots show all expressed genes. Red dots represent all KLA repressed-induced genes.</p><p id="P75">B. Hierarchical clustering and heatmap of the fold change in expression levels of KLA repressed-induced genes in WT and <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> bone marrow-derived macrophages treated with KLA for the indicated times (FDR &#x0003c; 0.01, RPKM &#x0003e; 0.5).</p><p id="P76">C. Relative mRNA expression of <em>Scd2</em> and <em>Fads2</em> in WT and <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> bone marrow-derived macrophages treated with KLA for the indicated times.</p><p id="P77">D. Relative mRNA expression of <em>Scd2</em> mRNA KLA-treated thioglycollate-elicited macrophages, transfected with siRNA control or targeting <em>Srebf1</em>.</p><p id="P78">E. Relative mRNA expression of <em>Scd2</em> mRNA KLA-treated thioglycollate-elicited macrophages, transfected with siRNA control or targeting <em>Scap</em>.</p><p id="P79">F. Distribution of RNA-Seq, H3K27ac and RNA Pol II tag densities at the <em>Scd2</em> locus in WT and <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> bone marrow-derived macrophages treated with KLA for 24 hours.</p><p id="P80">G. Distribution of H3K27Ac and RNA Pol II tag densities in the vicinity of enhancers associated with KLA repressed-induced genes in WT and <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> bone marrow-derived macrophages treated with KLA for the indicated times.</p><p id="P81">Values are expressed as mean &#x000b1; SEM. *p&#x0003c;0.05, **p&#x0003c;0.01.</p><p id="P82">See also Figure S4.</p></div></div></div><p id="P22">We independently confirmed the requirement of SREBP1 in the regulation of these genes by using small interfering RNAs (siRNAs) specifically targeting <em>Srebf1</em> or <em>Scap</em>. Quantitative PCR analysis indicated that the <em>Srebf1</em> knockdown was sufficient to inhibit the late phase inflammation induction of unsaturated fatty acid related gene expressions, exemplified by <em>Scd2</em> (<a href="/pmc/articles/PMC5568699/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5D</span></a>). RNA-Seq analysis further confirmed that siRNA-mediated <em>Srebf1</em> knockdown, led to significantly compromised late phase induction of many genes controlling synthesis of mono- and polyunsaturated fatty acids, including <em>Acsl3</em> and <em>Fads1/2</em>, in macrophages at 24 hours post KLA treatment (<a href="#SD1" rid="SD1" class=" supplementary-material">Suppl. Fig. 4B&#x02013;D</a>). Further, knockdown of <em>Scap</em>, which is required for SREBP processing and activation (<a href="#R15" rid="R15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088778">Horton et al., 2002</a>), resulted in a similar compromise in late phase induction of gene expression (<a href="/pmc/articles/PMC5568699/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5E</span></a>).</p><p id="P23">To gain further insight into the mechanism by which the repressed-induced gene expression is compromised in <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> macrophages, we performed ChIP-seq of H3K27ac and RNA pol II to evaluate local enhancer activity at KLA repressed-induced loci. Both H3K27ac and RNA pol II levels were markedly decreased at KLA 24 hours, in <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> macrophages, at KLA repressed-induced gene bodies, as exemplified by <em>Scd2</em> (<a href="/pmc/articles/PMC5568699/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5F</span></a>). Further, the normal temporal dynamics, characterized by late phase increase in both H3K27ac and RNA pol II levels, was globally compromised in <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> macrophages when looking at profiles for all KLA repressed-induced associated enhancers (<a href="/pmc/articles/PMC5568699/figure/F5/" target="figure" class="fig-table-link figpopup" rid-figpopup="F5" rid-ob="ob-F5" co-legend-rid="lgnd_F5"><span>Fig. 5G</span></a>), consistent with both the deficient late phase expression recovery, as measured by RNA-seq, and increased late recruitment of SREBP1 to these enhancers. These results suggest a significant role for SREBP1 in late phase induction of repressed-induced genes that control fatty acid biosynthesis.</p><p id="P24" class="p p-last">To investigate whether signaling through other TLRs would exert similar effects on SREBP1 target genes, we assessed relevant gene expression levels throughout a time course of PAM3CSK4 (TLR2 agonist) and Poly(I:C) (TLR3 agonist) treatment, comparing temporal responses in <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> and WT macrophages. Similar to the temporal dynamics of TLR4 activation, TLR2 and TLR3 responses of unsaturated fatty acid biosynthetic genes demonstrated a repressed-induced expression profile (<a href="#SD1" rid="SD1" class=" supplementary-material">Suppl. Fig. 4E&#x02013;F</a>) dependent on SREBP1. However, the induced phase was much more pronounced in the case of TLR2 activation. This result suggests a predominant role of the MyD88 pathway, which is used by both TLR4 and TLR2, but not TLR3, which instead signals primarily through TRIF.</p></div><div id="S8" class="sec sec-last"><h3>SREBP1 is necessary for resolution of the TLR-mediated inflammation</h3><p id="P25" class="p p-first">Previous studies demonstrated that unsaturated fatty acids such as EPA, DHA 9Z-POA have potent anti-inflammatory effects in macrophages by antagonizing inflammatory signaling through GPCRs, nuclear receptors and other mechanisms (<a href="#R2" rid="R2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088759">Cao et al., 2008</a>; <a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088746">Li et al., 2013</a>; <a href="#R27" rid="R27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088730">Oh et al., 2010</a>). To investigate whether the late phase of expression of genes involved in mono- and polyunsaturated fatty acid biosynthesis contributes to the resolution phase of TLR4 signaling, we evaluated the temporal expression profiles of genes that are induced following KLA treatment in wild type and <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> macrophages. Indeed, RNA-seq analysis revealed that <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> macrophages demonstrated delayed resolution and often exaggerated gene expression upon TLR4 activation, relative to their WT counterparts (<a href="/pmc/articles/PMC5568699/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Fig. 6A and B</span></a>). In WT macrophages, 964 significantly expressed transcripts (with RefSeq annotations) were detected that were increased &#x0003e; 2.0-fold at 6 hours after KLA treatment, and subsequently decreased &#x0003e; 2.0-fold at 24 hours post KLA treatment (defined herein as KLA induced-repressed genes). 247 of these induced-repressed genes demonstrated significantly increased expression, at 24 hours KLA treatment, in <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> macrophages compared to WT (<a href="/pmc/articles/PMC5568699/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Fig. 6A and B</span></a>). This set of KLA induced-repressed genes had significant enrichment of functional annotations for immune response, regulation of cytokine production and inflammatory response (<a href="/pmc/articles/PMC5568699/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Fig. 6C</span></a>). Quantitative PCR analysis confirmed that inflammatory gene expressions, as exemplified by <em>Nos</em>2, <em>Cxcl1</em>, <em>Cxcl9</em> and <em>Il1a</em>, are significantly increased at 24 hours KLA treatment in <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> macrophage (<a href="/pmc/articles/PMC5568699/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Fig. 6D</span></a>). Further, siRNA-mediated knockdown experiments confirmed the requirement of SREBP1 for appropriate resolution of inflammatory gene expression, as exemplified by <em>Cxcl2</em>, <em>Nos2</em>, <em>Cxcl1</em>, <em>Il1a</em>, <em>Il12b</em>, and <em>Il6</em> (<a href="#SD1" rid="SD1" class=" supplementary-material">Suppl. Fig. 5A</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F6" co-legend-rid="lgnd_F6"><a href="/pmc/articles/PMC5568699/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140071864774160" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5568699_nihms891846f6.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms891846f6.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC5568699/bin/nihms891846f6.jpg" /></a></div><div id="largeobj_idm140071864774160" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC5568699/figure/F6/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F6"><div><a class="figpopup" href="/pmc/articles/PMC5568699/figure/F6/" target="figure" rid-figpopup="F6" rid-ob="ob-F6">Figure 6</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong><em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> macrophages exhibit a hyper-inflammatory phenotype</strong><p id="P83">A. Scatter plot depicting the relationship between fold change of KLA induced-repressed genes, comparing RNA-seq from wild-type versus <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> bone marrow-derived macrophages treated with KLA for 24 hours. Gray dots show all uniquely expressed genes. Red dots represent all KLA induced-repressed genes.</p><p id="P84">B. Hierarchical clustering and heatmap of the fold change in expression levels of KLA induced-repressed genes, comparing RNA-seq data from WT and <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> bone marrow-derived macrophages treated with KLA for 24 hours (FDR &#x0003c; 0.01, RPKM &#x0003e; 0.5).</p><p id="P85">C. Functional annotations associated with KLA induced-repressed genes.</p><p id="P86">D. Relative mRNA expression of inflammatory genes in WT and <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> bone marrow-derived macrophages treated with KLA for the indicated times.</p><p id="P87">E. Distribution of RNA pol II tag densities at loci of KLA induced-repressed genes WT and <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> bone marrow-derived macrophages treated with KLA for indicated times.</p><p id="P88">F. UCSC genome browser image illustrating normalized tag counts for RNA-seq, RNA Pol II and p65 ChIP-seq at loci of inflammatory genes in WT and <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> bone marrow-derived macrophages treated with KLA for the indicated times.</p><p id="P89">Values are expressed as mean &#x000b1; SEM. *p&#x0003c;0.05, **p&#x0003c;0.01.</p><p id="P90">See also Figure S5.</p></div></div></div><p id="P26">We further assessed relevant pro-inflammatory gene expression levels throughout a time course of PAM3CSK4 (TLR2 agonist) and Poly(I:C) (TLR3 agonist) treatment, comparing temporal responses in <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> and WT macrophages. Similar to the temporal dynamics of TLR4 activation, TLR2 and TLR3 responses of pro-inflammatory genes demonstrated an induced-repressed expression profile (<a href="#SD1" rid="SD1" class=" supplementary-material">Suppl. Fig. 5E&#x02013;F</a>). Further, resolution of TLR2- and TLR3-mediated inflammatory gene expression was drastically compromised in <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> macrophages, relative to their WT counterparts (<a href="#SD1" rid="SD1" class=" supplementary-material">Suppl. Fig. 5E&#x02013;F</a>). Interestingly, Pam3 induced genes showed delayed resolution, similar to TLR4 response, whereas PolyI:C induced genes were hyper-responsive throughout the time course. These results are consistent with an MyD88-dependent induction of SREBP1 mediating late resolution of TLR2 and TLR4 responses. The hyper-activation of <em>Ifnb1</em> and <em>Ifna4</em> in response to TLR3 agonist in <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> macrophages may reflect a different mechanism.</p><p id="P27">To further define the SREBP-dependent temporal regulatory pattern, we analyzed ChIP-seq data for RNA polymerase II (RNA PolII) in KLA-treated <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> and WT macrophages. Normalized tag density plots at induced-repressed genes, revealed increased levels of RNA PolII in <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> versus WT macrophages (<a href="/pmc/articles/PMC5568699/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Fig. 6E</span></a>). The average tag density levels, between <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> and WT, demonstrated most significant differentials at 24 hours post KLA (<a href="/pmc/articles/PMC5568699/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Fig. 6E</span></a>). These distinct patterns are exemplified for <em>Cxcl2</em>, <em>Nos2</em>, <em>Cxcl1</em> and Il1a in <a href="/pmc/articles/PMC5568699/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Fig. 6F</span></a>. Consistent with ChIP-Seq and mRNA expression data, GRO-seq analysis revealed a similarly conserved temporal pattern of transcription at associated KLA induced-repressed gene bodies (<a href="#SD1" rid="SD1" class=" supplementary-material">Suppl. Fig. 5B</a>). These results suggest that the temporal dynamics of induced-repressed inflammatory genes are regulated via local enhancer activities driven by KLA responsive transcription factor complexes.</p><p id="P28">Given the role of NF&#x003ba;B as a primary driver of TLR4-mediated responses, we further performed ChIP-seq of the p65 component of NF&#x003ba;B to determine whether the increased inflammatory gene expression, exhibited by <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> macrophages, was due to increased p65 recruitment to the induced-repressed loci. Unexpectedly, the ChIP-seq analysis revealed a strikingly similar pattern of p65 binding in KLA treated <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> and WT macrophages (<a href="/pmc/articles/PMC5568699/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Fig. 6F</span></a> and <a href="#SD1" rid="SD1" class=" supplementary-material">Suppl. Fig. 5C, D</a>). Further, the similarity of p65 binding, comparing <em>Srebf1</em><sup>&#x02212;/&#x02212;</sup> and WT profiles, remains consistent whether looking at all repressed-induced loci (correlation coefficient = 0.949817), or the subset of induced-repressed loci demonstrating the most significant alterations upon loss of Srebp1 (correlation coefficient = 0.9438753) (<a href="#SD1" rid="SD1" class=" supplementary-material">Suppl. Fig. 5C&#x02013;D</a>). This finding is consistent with previous studies suggesting that the repressive actions of unsaturated fatty acids on NF&#x003ba;B activity are independent of changes in factor binding (<a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088789">Li et al., 2013</a>).</p><p id="P29">The gene expression pattern observed in <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> macrophages predicts that the late phase of mono- and poly-unsaturated fatty acid production would be compromised in these cells. We therefore performed lipidomic analysis of KLA-treated <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> and wild type macrophages to assess changes in fatty acid levels. Consistent with the altered gene expression patterns, <em>Srebf1</em><sup>&#x02212;/&#x02212;</sup> macrophages demonstrated marked decreases in unsaturated fatty acid production, as exemplified by DHA, EPA, and 9Z&#x02013;POA; with most dramatic differentials, between <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> and WT macrophages, occurring at 24 hours post KLA treatment (<a href="/pmc/articles/PMC5568699/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Fig. 7A</span></a>, <a href="#SD1" rid="SD1" class=" supplementary-material">Suppl. Fig. 6A</a>). This late phase-specific decrease is consistent with the possibility that these anti-inflammatory fatty acids contribute to the resolution phase of the TLR4 response.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F7" co-legend-rid="lgnd_F7"><a href="/pmc/articles/PMC5568699/figure/F7/" target="figure" rid-figpopup="F7" rid-ob="ob-F7"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140071989563440" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=5568699_nihms891846f7.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is nihms891846f7.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC5568699/bin/nihms891846f7.jpg" /></a></div><div id="largeobj_idm140071989563440" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC5568699/figure/F7/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F7"><div><a class="figpopup" href="/pmc/articles/PMC5568699/figure/F7/" target="figure" rid-figpopup="F7" rid-ob="ob-F7">Figure 7</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>SREBP1 is necessary for resolution of inflammation by driving appropriate macrophage production of anti-inflammatory unsaturated fatty acids in late inflammatory response</strong><p id="P91">A. Lipidomics analysis of unsaturated fatty acid (EPA and DHA 9Z&#x02013;PO) levels in KLA treated WT and <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> bone marrow-derived macrophages.</p><p id="P92">B. Relative mRNA expression of inflammatory genes in WT and <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> bone marrow-derived macrophages treated with KLA for 24 hours, with or without supplementation with the indicated exogenous fatty acids (20&#x000b5;M) at 12h post KLA treatment.</p><p id="P93">C. Serum levels of cytokines IL-6 and IL-1a, as quantified by ELISA, in WT and <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> mice treated with 5mg/kg LPS for 0, 1, 3, 6, 24 hours, with or without EPA supplementation as indicated.</p><p id="P94">D. Model for integrated actions of NF&#x003ba;B, LXRs and SREBP1 during the induction and resolution phases of the TLR4 response.</p><p id="P95">Values are expressed as mean &#x000b1; SEM. *p&#x0003c;0.05, **p&#x0003c;0.01.</p><p id="P96">See also Figure S6.</p></div></div></div><p id="P30">To further test the link between late phase resolution of inflammation and unsaturated fatty acid output, fatty acid rescue experiments were performed, in which exogenous unsaturated fatty acids were added to KLA-treated <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> and WT macrophages. In these experiments, mono- (9Z-POA) and poly-unsaturated (EPA/DHA) fatty acids were supplemented, either alone or simultaneously, at 12 hours post KLA treatment to mimic late phase accumulation. Cells were then harvested at 24 hours after KLA treatment. Addition of exogenous unsaturated fatty acids led to significant reduction of inflammatory gene expression in macrophages (<a href="/pmc/articles/PMC5568699/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Fig. 7B</span></a>). Further, this unsaturated fatty acid-specific repressive effect was more pronounced in <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> cells, relative to their WT counterparts (<a href="/pmc/articles/PMC5568699/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Fig. 7B</span></a>), consistent with intact production of these fatty acid species in WT macrophages. Similar results were observed in siRNA-mediated knockdown cells (<a href="#SD1" rid="SD1" class=" supplementary-material">Suppl. Fig. 6B</a>).</p><p id="P31" class="p p-last">To investigate the role of SREBP1-mediated unsaturated fatty acid output in modulating the inflammatory response <em>in vivo</em>, <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> mice were challenged with a sub-lethal dose of LPS. Consistent with the increased late phase inflammatory gene expression patterns observed in the <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> macrophages (<a href="/pmc/articles/PMC5568699/figure/F6/" target="figure" class="fig-table-link figpopup" rid-figpopup="F6" rid-ob="ob-F6" co-legend-rid="lgnd_F6"><span>Fig. 6B&#x02013;F</span></a>), circulating cytokine levels of IL-6 and IL-1&#x003b1; remained significantly higher in <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> mice, at 24 hours post LPS injection (<a href="/pmc/articles/PMC5568699/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Fig. 7C</span></a>); thus suggesting a compromised resolution of inflammation relative to their WT counterparts. In addition, supplementation of exogenous EPA, prior to the LPS challenge, protected <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> mice from an exaggerated inflammatory response, restoring circulating cytokine levels to those seen in WT mice (<a href="/pmc/articles/PMC5568699/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Fig. 7C</span></a>).</p></div></div><div id="S9" class="tsec sec"><h2 class="head no_bottom_margin" id="S9title">Discussion</h2><p id="P32" class="p p-first">Emerging evidence suggests that the immune system and lipid metabolism are coordinately regulated at multiple levels within the body. Here, we demonstrate a reciprocal relationship between cellular levels of anti-inflammatory fatty acids and the temporal induction and resolution of pro-inflammatory gene expression following TLR4 activation (<a href="/pmc/articles/PMC5568699/figure/F7/" target="figure" class="fig-table-link figpopup" rid-figpopup="F7" rid-ob="ob-F7" co-legend-rid="lgnd_F7"><span>Fig. 7D</span></a>). Anti-inflammatory fatty acid levels rapidly fall following KLA treatment, in advance of down regulation of mRNAs encoding corresponding biosynthetic enzymes. Given the ability of these fatty acid species to suppress NF-&#x003ba;B-dependent gene expression, their down regulation is likely to be necessary for a full TLR4 response. At 12-24h following TLR4 ligation, anti-inflammatory fatty acid levels rise, concurrent with increased expression of mRNAs encoding biosynthetic enzymes and decreased expression of mRNAs encoding pro-inflammatory mediators.</p><p id="P33">Mechanisms responsible for down-regulation of lipid biosynthetic genes remain to be established. Repression of basal LXR-dependent gene expression does not account for this effect because a similar pattern of gene expression was observed in LXR double knockout macrophages. Thus, while TLR signaling blunts the ability of LXR agonists to induce target gene expression, alternative mechanisms must account for the observed down-regulation. During the initial phase of the TLR4 response, the p65 component of NF- &#x003ba;B is recruited to many of the enhancer elements associated with the set of repressed-induced genes. This TLR-induced p65 binding is associated with loss of both coactivator recruitment and active chromatin features at these loci, correlating with their loss of transcriptional activity and expression. Our unpublished results using an NF- &#x003ba;B inhibitor, suggest a requirement for NF- &#x003ba;B activity in mediating the early phase repression of these genes (data not shown). However, a direct role of p65-containing NF-&#x003ba;B complexes in down regulation of these genes remains to be established.</p><p id="P34">Unexpectedly, the late up-regulation of mRNAs encoding enzymes required for synthesis of anti-inflammatory fatty acids was independent of LXRs and instead required SREBP1. Consistent with these findings, ChIP-Seq experiments indicated a reduction of LXR binding to enhancers associated with repressed-induced genes, but a marked increase in the binding of SREBP1. This KLA-induced binding of SREBP1 to cis regulatory elements at late time points was associated with increases in the total nuclear content of processed SREBP1. Further, the late increase in SREBP1 binding was associated with increases in chromatin features associated with active enhancers. SREBP1 KO macrophages, or macrophages in which siRNAs were used to knock down SREBP1, displayed compromised late induction of repressed-induced genes and reduced production of anti-inflammatory fatty acids. While our data clearly provides evidence for a novel role of SREBP1 in transcriptionally tailoring specific macrophage lipid metabolic output, driving late phase synthesis of anti-inflammatory unsaturated fatty acids, the mechanisms controlling both the late phase induction of SREBP1 recruitment and the SREBP1-target activation specificity are not entirely clear. An understanding of these mechanisms could be of importance in identifying novel targets for development of SREBP1-centric interventions of various inflammatory disease states.</p><p id="P35">Recent studies provided evidence that SREBP-1a is required for the formation of the inflammasome and secretion of IL-1&#x003b2; in response to systemic inflammation (such as endotoxic shock) (<a href="#R18" rid="R18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088782">Im et al., 2011</a>). Consistent with these findings, we observed increased secretion of IL-1&#x003b2; protein following KLA treatment of <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> macrophages as compared to WT controls (data not shown). However, our studies also demonstrated that a subset of TLR4-responsive, pro-inflammatory genes was hyper-activated in <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> macrophages at 12&#x02013;24 hours following KLA treatment. Similar late hyper-inflammatory trends were observed in <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> macrophages stimulated with ligands for TLR2 and TLR3; thus, indicating that SREBP1 is genetically required for the normal resolution phase of varied TLR responses in macrophages. Our findings further suggest that SREBP1-driven synthesis of anti-inflammatory fatty acids contributes to this resolution phase. The late TLR4-mediated increase of these fatty acid species is compromised in <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> macrophages, and supplementation of exogenous anti-inflammatory, both in cultured macrophages and <em>in vivo</em>, reverses hyper-induction of pro-inflammatory gene expression caused by loss of SREBP1. This is consistent with the presence of higher concentrations of these species in WT macrophages. Although our studies focused on 9Z-POA, DHA and EPA, it is possible that additional anti-inflammatory metabolites of polyunsaturated fatty acids, such as resolvins protectins and fatty acid hydroxyl fatty acids, are also generated by the late SREBP1-dependent program of gene expression. Interestingly, loss of SREBP1 results in increased recruitment of RNA-Pol II to a subset of inflammatory response genes independent of changes in p65 binding activity. These results are consistent with prior studies suggesting that DHA, EPA and 9Z-POA uncouple NF-&#x003ba;B binding from its transcriptional output (<a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088740">Li et al., 2013</a>). Because p65 binding itself is unchanged, the mechanism of inhibition is unlikely to be through alterations in the I&#x003ba;B kinase cascade required for NF-&#x003ba;B activation.</p><p id="P36" class="p p-last">In concert, our findings provide evidence for a role of SREBP1 in promoting resolution of the transcriptional response of macrophages to TLR signaling by driving the synthesis of anti-inflammatory fatty acids. While we have shown that the SREBP1 pathway also influences resolution following activation of TLR2 and TLR3, the extent to which it is involved in resolution of responses to other pattern recognition receptors or cytokine-dependent inflammatory responses remains to be determined. It will therefore be of interest to investigate this pathway further with respect to control of the resolution phase of inflammation in response to infection and injury, as well as in disease contexts in which inflammation plays a pathogenic role.</p></div><div id="S10" class="tsec sec"><h2 class="head no_bottom_margin" id="S10title">Experimental procedures</h2><div id="S11" class="sec sec-first"><h3>Cell culture</h3><p id="P37" class="p p-first-last"><em>LXR&#x003b1;/&#x003b2;</em><sup>&#x02212;/&#x02212;</sup> and <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> were generated as described previously (<a href="#R33" rid="R33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088769">Repa et al., 2000b</a>; <a href="#R36" rid="R36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088786">Shimano et al., 1997</a>). These mice were backcrossed to the C57BL/6J strain for more than ten generations. Mouse thioglycollate-elicited macrophages and were isolated from male 6- to 9- weeks old C57BL/6J (Charles River laboratories), <em>LXR&#x003b1;/&#x003b2;</em><sup>&#x02212;/&#x02212;</sup> and <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> mice and cultured as previously described (<a href="#R37" rid="R37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088760">Spann et al., 2012</a>). Peritoneal macrophages were harvested by lavage 3 days after intraperitoneal injection of 3ml of 3% thioglycollate medium (<a href="http://www.lipidmaps.org/protocols/" ref="reftype=extlink&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">http://www.lipidmaps.org/protocols/</a>), overnight culture and adherence selection. Bone marrow from mice were isolated by perfusion of the medullary cavity of femurs, tibias and iliac bones and cultured in medium containing RPMI-1640, 10% FCS, and 20ug/ml M-CSF (R&#x00026;D) for 6 days. RAW264.7 cells are maintained in the RPMI 1640 media supplemented with 10% FCS (Hyclone) and used between passage 5&#x02013;10. For the fatty acid rescue experiments, cells were treated with fatty acids complexed with FA-free low-endotoxin BSA (Sigma, final FA:BSA molar ratio was 5:1).</p></div><div id="S12" class="sec"><h3>Animal Study</h3><p id="P38" class="p p-first-last">All mice used in this study has C57BL/6 background. Male, 8&#x02013;11 weeks old <em>Srebf1<sup>&#x02212;/&#x02212;</sup></em> mice and age-matched littermate control were individually housed in cages in a 12hr/12hr light/dark cycle with free access to food and water. For supplemental EPA administration study, mice were fed with fish meal-free diet (fish meal-free F1: 4.4% fat; Funabashi Farm, Funabashi, Japan) or fish meal-free diet supplemented with 5% EPA ethyl ester (v/v) for 7 days before single intraperitoneal injection of 5mg/kg LPS (n=5, each group). All animal procedures were in accordance with research guidelines for care and use of laboratory animals of Tokyo Medial and Dental University. Temporal changes of serum IL-6 and IL-1a were quantified by ELISA (R&#x00026;D).</p></div><div id="S13" class="sec"><h3>ChIP-Seq</h3><p id="P39" class="p p-first-last">ChIP from thioglycollate-elicited peritoneal macrophages or bone marrow-derived macrophages were performed as described previously (<a href="#R37" rid="R37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088781">Spann et al., 2012</a>), with modifications as described in <a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Experimental Procedures</a>. ChIP-Seq libraries were prepared from ChIP DNA by blunting, A-tailing, adapter ligation as previously described (<a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088798">Heinz, et al. 2010</a>) using barcoded adapters (NextFlex, Bioo Scientific). Libraries were PCR-amplified for 12&#x02013;15 cycles, size selected by gel extraction and sequenced on either Illumina Genome Analyzer II Hi-Seq 2000 for 51 cycles.</p></div><div id="S14" class="sec"><h3>RNA-Seq</h3><p id="P40" class="p p-first-last">Total RNA was isolated from cells and purified using RNeasy columns and RNase free DNase digestion according to the manufacturer's instructions (QIAGEN). RNA-Seq libraries were prepared from polyA enriched mRNA, either as previously described (<a href="#R22" rid="R22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088743">Kaikkonen, et al. 2013</a>), or as detailed in <a href="#SD1" rid="SD1" class=" supplementary-material">Supplemental Experimental Procedures</a>.</p></div><div id="S15" class="sec"><h3>High-throughput sequencing and data analysis</h3><p id="P41" class="p p-first-last">All sequencing was conducted using either Illumina Genome Analyzer II or Hi-Seq 2000 sequencers using single-end 50bp reads. All data were aligned to the mm9 assembly of the mouse genome, and all subsequent data analysis was performed using HOMER, and detailed instructions for analysis can be found at <a href="http://homer.salk.edu/homer/" ref="reftype=extlink&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">http://homer.salk.edu/homer/</a> (<a href="#R13" rid="R13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088787">Heinz et al., 2010</a>). Each sequencing experiment was normalized to total of 10<sup>7</sup> uniquely mapped tags by adjusting the number of tags at each position in the genome to the correct fractional amount given the total tags mapped. Sequence experiments were visualized by preparing custom tracks for the UCSC genome browser. Differentially expressed genes were identified using HOMER as described previously (<a href="#R23" rid="R23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_633088738">Li et al., 2013</a>). For SREBP1 ChIP-Seq analysis, ChIP-seq peaks for each SREBP ChIP replicate were identified using Homer and then the strength of binding at each loci was quantified as the position adjusted reads from the start of the peak region (Homer peak score). We calculated the Irreproducible Discovery Rate (IDR) to measure the consistency between replicate experiments for the strength of binding at each loci and retained SREBP peaks with IDR &#x0003c; 0.05. For various ontology analyses, either HOMER or DAVID Bioinformatics Resources 6.7 was used.</p></div><div id="S16" class="sec sec-last"><h3>Statistical analyses</h3><p id="P42" class="p p-first-last">Statistical analyses were performed using Graph Pad Prism 5 software. The images were prepared using Adobe Illustrator CS5 or Photoshop CS5.1. Data are presented as the mean &#x000b1; SEM. For experiments involving two factors, data were analyzed by two-way ANOVA followed by Bonferroni post tests. Individual pair-wise comparisons were performed using Student&#x02019;s t test. p &#x0003c; 0.05 was considered significant.</p></div></div><div id="SM" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="SMtitle">Supplementary Material</h2><!--/article/body/sec/--><div class="sec suppmat" id="SD1"><h4>1</h4><div class="sup-box half_rhythm" id="d36e1273"><a href="/pmc/articles/PMC5568699/bin/NIHMS891846-supplement-1.pdf">Click here to view.</a><sup>(616K, pdf)</sup></div></div><div class="sec suppmat" id="SD2"><h4>2</h4><div class="sup-box half_rhythm" id="d36e1277"><a href="/pmc/articles/PMC5568699/bin/NIHMS891846-supplement-2.pdf">Click here to view.</a><sup>(149K, pdf)</sup></div></div><div class="sec suppmat" id="SD3"><h4>3</h4><div class="sup-box half_rhythm" id="d36e1281"><a href="/pmc/articles/PMC5568699/bin/NIHMS891846-supplement-3.pdf">Click here to view.</a><sup>(144K, pdf)</sup></div></div><div class="sec suppmat" id="SD4"><h4>4</h4><div class="sup-box half_rhythm" id="d36e1285"><a href="/pmc/articles/PMC5568699/bin/NIHMS891846-supplement-4.pdf">Click here to view.</a><sup>(709K, pdf)</sup></div></div><div class="sec suppmat" id="SD5"><h4>5</h4><div class="sup-box half_rhythm" id="d36e1289"><a href="/pmc/articles/PMC5568699/bin/NIHMS891846-supplement-5.pdf">Click here to view.</a><sup>(3.0M, pdf)</sup></div></div><div class="sec suppmat" id="SD6"><h4>6</h4><div class="sup-box half_rhythm" id="d36e1293"><a href="/pmc/articles/PMC5568699/bin/NIHMS891846-supplement-6.pdf">Click here to view.</a><sup>(1.2M, pdf)</sup></div></div><div class="sec suppmat" id="SD7"><h4>7</h4><div class="sup-box half_rhythm" id="d36e1297"><a href="/pmc/articles/PMC5568699/bin/NIHMS891846-supplement-7.pdf">Click here to view.</a><sup>(371K, pdf)</sup></div></div></div><div id="S17" class="tsec sec"><h2 class="head no_bottom_margin" id="S17title">Acknowledgments</h2><div class="sec"><p id="P47">We thank Dr. Timothy Osborne for making anti-SREBP1 antibodies available for these studies. We thank Dr. Kristen Jepsen, Mahdieh Khosroheidari, and Hiroko Matsui for assistance with Illumina sequencing; Jana Collier for technical assistance; Miguel Mooney for technical assistance; and Leslie Van Ael for assistance with manuscript preparation. Y.O. was supported by MEXT KAKENHI Grant Numbers 24641142 and 25H10, grants from Naito Foundation, Japan Heart Foundation, Japan Foundation for applied enzymology, Ono medical foundation and Takeda Science Foundation. M.U.K. was supported by Fondation Leducq Career Development award, Academy of Finland Research Fellowship and grants from Sigrid Jus&#x000e9;lius, ASLA-Fulbright, Finnish Foundation for Cardiovascular Research and Finnish Cultural Foundation. T.S. was supported by funding from the Swedish Society for Medical Research. Studies were primarily supported by NIH grants DK091183, CA17390, and DK063491.</p></div></div><div id="idm140072028201328" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140072028201328title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><div><p id="P43" class="p p-first"><strong>Author Contributions</strong></p>Y.O., N.J.S. and C.K.G. conceived project and designed experiments. Y.O., N.J.S., V.M.L. and J.T. analyzed data. Y.O., N.J.S., T.S., C.E., E.D.M., T.M., S.H., M.U.K., A.F.C., M.J.K. and M.T.L. performed experiments. H.S. provided mice. M.J.K., I.M., and A.S., provided technical expertise. Y.O., N.J.S. and C.K.G. interpreted data and wrote the manuscript.</div><p class="fn sec" id="FN5"><p id="P45" class="p p-first"><strong>Accession Numbers</strong></p><p id="P46" class="p p-last">Sequencing data supporting these studies can be found at the Gene Expression Omnibus database under accession numbers <a id="__tag_633088805" class="tag_hotlink" href="/geo/query/acc.cgi?acc=GSE79423" ref="/geo/query/acc.cgi?acc=GSE79423"><span class="tag-json" style="display:none">{"type":"entrez-geo","attrs":{"text":"GSE79423","term_id":"79423"}}</span>GSE79423</a>. Data from previously published GRO-Seq and ChIP-Seq experiments can be found under accession number <a id="__tag_633088804" class="tag_hotlink" href="/geo/query/acc.cgi?acc=GSE48759" ref="/geo/query/acc.cgi?acc=GSE48759"><span class="tag-json" style="display:none">{"type":"entrez-geo","attrs":{"text":"GSE48759","term_id":"48759"}}</span>GSE48759</a>.</p></p></div></div><div id="idm140071859414336" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140071859414336title">References</h2><div class="ref-list-sec sec" id="reference-list"><ul class="back-ref-list" style="list-style-type:decimal;"><li id="R1"><span class="element-citation">Calkin AC, Tontonoz P. Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. <span><span class="ref-journal">Nat Rev Mol Cell Biol. </span>2012;<span class="ref-vol">13</span>:213–224.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3597092/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/22414897" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R2"><span class="element-citation">Cao H, Gerhold K, Mayers JR, Wiest MM, Watkins SM, Hotamisligil GS. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. <span><span class="ref-journal">Cell. </span>2008;<span class="ref-vol">134</span>:933–944.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2728618/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/18805087" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R3"><span class="element-citation">Castrillo A, Joseph SB, Vaidya SA, Haberland M, Fogelman AM, Cheng G, Tontonoz P. Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. <span><span class="ref-journal">Mol Cell. </span>2003;<span class="ref-vol">12</span>:805–816.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/14580333" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R4"><span class="element-citation">Cildir G, Akincilar SC, Tergaonkar V. Chronic adipose tissue inflammation: all immune cells on the stage. <span><span class="ref-journal">Trends Mol Med. </span>2013;<span class="ref-vol">19</span>:487–500.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/23746697" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R5"><span class="element-citation">Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ, Hanna J, Lodato MA, Frampton GM, Sharp PA, et al.  Histone H3K27ac separates active from poised enhancers and predicts developmental state. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2010;<span class="ref-vol">107</span>:21931–21936.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3003124/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/21106759" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R6"><span class="element-citation">Dennis EA, Deems RA, Harkewicz R, Quehenberger O, Brown HA, Milne SB, Myers DS, Glass CK, Hardiman G, Reichart D, et al.  A mouse macrophage lipidome. <span><span class="ref-journal">J Biol Chem. </span>2010;<span class="ref-vol">285</span>:39976–39985.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3000979/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/20923771" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R7"><span class="element-citation">Feingold KR, Shigenaga JK, Kazemi MR, McDonald CM, Patzek SM, Cross AS, Moser A, Grunfeld C. Mechanisms of triglyceride accumulation in activated macrophages. <span><span class="ref-journal">J Leukoc Biol. </span>2012;<span class="ref-vol">92</span>:829–839.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3441312/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/22753953" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R8"><span class="element-citation">Ghisletti S, Huang W, Jepsen K, Benner C, Hardiman G, Rosenfeld MG, Glass CK. Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways. <span><span class="ref-journal">Genes Dev. </span>2009;<span class="ref-vol">23</span>:681–693.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2661610/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19299558" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R9"><span class="element-citation">Glass CK, Natoli G. Molecular control of activation and priming in macrophages. <span><span class="ref-journal">Nat Immunol. </span>2015;<span class="ref-vol">17</span>:26–33.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4795476/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/26681459" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R10"><span class="element-citation">Goldstein JL, DeBose-Boyd RA, Brown MS. Protein sensors for membrane sterols. <span><span class="ref-journal">Cell. </span>2006;<span class="ref-vol">124</span>:35–46.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16413480" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R11"><span class="element-citation">Gonzalez A, Bensinger SJ, Hong C, Beceiro S, Bradley MN, Zelcer N, Deniz J, Ramirez C, Diaz M, Gallardo G, et al.  Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. <span><span class="ref-journal">Immunity. </span>2009;<span class="ref-vol">31</span>:245–258.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2791787/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19646905" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R12"><span class="element-citation">He HH, Meyer CA, Shin H, Bailey ST, Wei G, Wang Q, Zhang Y, Xu K, Ni M, Lupien M, et al.  Nucleosome dynamics define transcriptional enhancers. <span><span class="ref-journal">Nat Genet. </span>2010;<span class="ref-vol">42</span>:343–347.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2932437/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/20208536" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R13"><span class="element-citation">Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, Glass CK. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. <span><span class="ref-journal">Mol Cell. </span>2010;<span class="ref-vol">38</span>:576–589.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2898526/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/20513432" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R14"><span class="element-citation">Hong C, Tontonoz P. Liver X receptors in lipid metabolism: opportunities for drug discovery. <span><span class="ref-journal">Nat Rev Drug Discov. </span>2014;<span class="ref-vol">13</span>:433–444.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/24833295" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R15"><span class="element-citation">Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. <span><span class="ref-journal">J Clin Invest. </span>2002;<span class="ref-vol">109</span>:1125–1131.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC150968/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/11994399" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R16"><span class="element-citation">Huang SC, Everts B, Ivanova Y, O'Sullivan D, Nascimento M, Smith AM, Beatty W, Love-Gregory L, Lam WY, O'Neill CM, et al.  Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages. <span><span class="ref-journal">Nat Immunol. </span>2014a;<span class="ref-vol">15</span>:846–855.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4139419/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/25086775" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R17"><span class="element-citation">Huang YL, Morales-Rosado J, Ray J, Myers TG, Kho T, Lu M, Munford RS. Toll-like receptor agonists promote prolonged triglyceride storage in macrophages. <span><span class="ref-journal">J Biol Chem. </span>2014b;<span class="ref-vol">289</span>:3001–3012.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3908431/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/24337578" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R18"><span class="element-citation">Im SS, Yousef L, Blaschitz C, Liu JZ, Edwards RA, Young SG, Raffatellu M, Osborne TF. Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a. <span><span class="ref-journal">Cell Metab. </span>2011;<span class="ref-vol">13</span>:540–549.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3090630/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/21531336" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R19"><span class="element-citation">Ito A, Hong C, Rong X, Zhu X, Tarling EJ, Hedde PN, Gratton E, Parks J, Tontonoz P. LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling. <span><span class="ref-journal">Elife. </span>2015;<span class="ref-vol">4</span>:e08009.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4517437/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/26173179" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R20"><span class="element-citation">Iyer SS, Ghaffari AA, Cheng G. Lipopolysaccharide-mediated IL-10 transcriptional regulation requires sequential induction of type I IFNs and IL-27 in macrophages. <span><span class="ref-journal">J Immunol. </span>2010;<span class="ref-vol">185</span>:6599–6607.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4103176/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/21041726" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R21"><span class="element-citation">Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. <span><span class="ref-journal">Nat Med. </span>2003;<span class="ref-vol">9</span>:213–219.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/12524534" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R22"><span class="element-citation">Kaikkonen MU, Spann NJ, Heinz S, Romanoski CE, Allison KA, Stender JD, Chun HB, Tough DF, Prinjha RK, Benner C, et al.  Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription. <span><span class="ref-journal">Mol Cell. </span>2013;<span class="ref-vol">51</span>:310–325.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3779836/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/23932714" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R23"><span class="element-citation">Li P, Spann NJ, Kaikkonen MU, Lu M, Oh da Y, Fox JN, Bandyopadhyay G, Talukdar S, Xu J, Lagakos WS, et al.  NCoR repression of LXRs restricts macrophage biosynthesis of insulin-sensitizing omega 3 fatty acids. <span><span class="ref-journal">Cell. </span>2013;<span class="ref-vol">155</span>:200–214.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4131699/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/24074869" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R24"><span class="element-citation">Lumeng CN, DelProposto JB, Westcott DJ, Saltiel AR. Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. <span><span class="ref-journal">Diabetes. </span>2008;<span class="ref-vol">57</span>:3239–3246.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2584129/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/18829989" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R25"><span class="element-citation">Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M. Macrophage plasticity and polarization in tissue repair and remodelling. <span><span class="ref-journal">J Pathol. </span>2013;<span class="ref-vol">229</span>:176–185.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/23096265" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R26"><span class="element-citation">Medzhitov R, Horng T. Transcriptional control of the inflammatory response. <span><span class="ref-journal">Nat Rev Immunol. </span>2009;<span class="ref-vol">9</span>:692–703.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19859064" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R27"><span class="element-citation">Oh da Y, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, Li P, Lu WJ, Watkins SM, Olefsky JM. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. <span><span class="ref-journal">Cell. </span>2010;<span class="ref-vol">142</span>:687–698.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2956412/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/20813258" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R28"><span class="element-citation">Osborn O, Olefsky JM. The cellular and signaling networks linking the immune system and metabolism in disease. <span><span class="ref-journal">Nat Med. </span>2012;<span class="ref-vol">18</span>:363–374.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/22395709" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R29"><span class="element-citation">Ostuni R, Piccolo V, Barozzi I, Polletti S, Termanini A, Bonifacio S, Curina A, Prosperini E, Ghisletti S, Natoli G. Latent enhancers activated by stimulation in differentiated cells. <span><span class="ref-journal">Cell. </span>2013;<span class="ref-vol">152</span>:157–171.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/23332752" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R30"><span class="element-citation">Raetz CR, Garrett TA, Reynolds CM, Shaw WA, Moore JD, Smith DC, Jr, Ribeiro AA, Murphy RC, Ulevitch RJ, Fearns C, et al.  Kdo2-Lipid A of Escherichia coli, a defined endotoxin that activates macrophages via TLR-4. <span><span class="ref-journal">J Lipid Res. </span>2006;<span class="ref-vol">47</span>:1097–1111.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16479018" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R31"><span class="element-citation">Reboldi A, Dang EV, McDonald JG, Liang G, Russell DW, Cyster JG. Inflammation. 25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon. <span><span class="ref-journal">Science. </span>2014;<span class="ref-vol">345</span>:679–684.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4289637/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/25104388" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R32"><span class="element-citation">Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro JM, Shimomura I, Shan B, Brown MS, Goldstein JL, Mangelsdorf DJ. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. <span><span class="ref-journal">Genes Dev. </span>2000a;<span class="ref-vol">14</span>:2819–2830.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC317055/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/11090130" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R33"><span class="element-citation">Repa JJ, Turley SD, Lobaccaro JA, Medina J, Li L, Lustig K, Shan B, Heyman RA, Dietschy JM, Mangelsdorf DJ. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. <span><span class="ref-journal">Science. </span>2000b;<span class="ref-vol">289</span>:1524–1529.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/10968783" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R34"><span class="element-citation">Rodriguez-Prados JC, Traves PG, Cuenca J, Rico D, Aragones J, Martin-Sanz P, Cascante M, Bosca L. Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. <span><span class="ref-journal">J Immunol. </span>2010;<span class="ref-vol">185</span>:605–614.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/20498354" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R35"><span class="element-citation">Schultz JR, Tu H, Luk A, Repa JJ, Medina JC, Li L, Schwendner S, Wang S, Thoolen M, Mangelsdorf DJ, et al.  Role of LXRs in control of lipogenesis. <span><span class="ref-journal">Genes Dev. </span>2000;<span class="ref-vol">14</span>:2831–2838.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC317060/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/11090131" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R36"><span class="element-citation">Shimano H, Shimomura I, Hammer RE, Herz J, Goldstein JL, Brown MS, Horton JD. Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene. <span><span class="ref-journal">J Clin Invest. </span>1997;<span class="ref-vol">100</span>:2115–2124.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC508404/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/9329978" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R37"><span class="element-citation">Spann NJ, Garmire LX, McDonald JG, Myers DS, Milne SB, Shibata N, Reichart D, Fox JN, Shaked I, Heudobler D, et al.  Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses. <span><span class="ref-journal">Cell. </span>2012;<span class="ref-vol">151</span>:138–152.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3464914/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/23021221" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R38"><span class="element-citation">Spann NJ, Glass CK. Sterols and oxysterols in immune cell function. <span><span class="ref-journal">Nat Immunol. </span>2013;<span class="ref-vol">14</span>:893–900.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/23959186" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R39"><span class="element-citation">Tabas I, Glass CK. Anti-inflammatory therapy in chronic disease: challenges and opportunities. <span><span class="ref-journal">Science. </span>2013;<span class="ref-vol">339</span>:166–172.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3608517/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/23307734" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R40"><span class="element-citation">Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, Frezza C, Bernard NJ, Kelly B, Foley NH, et al.  Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha. <span><span class="ref-journal">Nature. </span>2013;<span class="ref-vol">496</span>:238–242.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4031686/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/23535595" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R41"><span class="element-citation">Tencerova M, Aouadi M, Vangala P, Nicoloro SM, Yawe JC, Cohen JL, Shen Y, Garcia-Menendez L, Pedersen DJ, Gallagher-Dorval K, et al.  Activated Kupffer cells inhibit insulin sensitivity in obese mice. <span><span class="ref-journal">FASEB J. </span>2015;<span class="ref-vol">29</span>:2959–2969.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4478794/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/25805830" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R42"><span class="element-citation">Varma V, Yao-Borengasser A, Rasouli N, Nolen GT, Phanavanh B, Starks T, Gurley C, Simpson P, McGehee RE, Jr, Kern PA, et al.  Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action. <span><span class="ref-journal">Am J Physiol Endocrinol Metab. </span>2009;<span class="ref-vol">296</span>:E1300–1310.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2692398/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19336660" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R43"><span class="element-citation">Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. <span><span class="ref-journal">Nature. </span>2013;<span class="ref-vol">496</span>:445–455.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3725458/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/23619691" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li><li id="R44"><span class="element-citation">Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. <span><span class="ref-journal">J Clin Invest. </span>2003;<span class="ref-vol">112</span>:1821–1830.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC296998/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/14679177" target="pmc_ext" ref="reftype=pubmed&amp;article-id=5568699&amp;issue-id=297398&amp;journal-id=319&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></li></ul></div></div></div><!--post-content--></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC5568699/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC5568699/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC5568699/pdf/nihms891846.pdf">PDF (3.0M)</a></li> | <li><a href="#" data-citationid="PMC5568699" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5568699%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5568699%2F&amp;text=SREBP1%20contributes%20to%20resolution%20of%20pro-inflammatory%20TLR4%20signaling%20by%20reprogramming%20fatty%20acid%20metabolism"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5568699%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="28041958" data-aiid="5568699" data-aid="5568699" data-iid="297398" data-domainid="319" data-domain="nihpa" data-accid="PMC5568699" data-md5="3209a11d146eaa083e24335fae078500"></div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2018-07-16T20:36:01-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc202&amp;ncbi_phid=F4FC2E4DB4D384510000000000CC00C9&amp;ncbi_session=F4FC2E4DB4D39F11_0204SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5568699%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=nihpa&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC5568699/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- F4FC2E4DB4D39F11_0204SID /projects/PMC/PMCViewer@4.46 ptpmc202 v4.1.r563004 Tue, May 01 2018 03:01:28 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>
</html>